BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 30, 2004
View Archived Issues
Genistein reported to reduce hot flushes in postmenopausal women
Read More
Pergolide improves erectile dysfunction in male patients with advanced PD
Read More
FL-61, a potent new urotensin-II agonist, under early evaluation at Acadia
Read More
Combio synthesizes potent and selective DPPI inhibitors using lead optimization technology
Read More
Antiangiogenic agents targeting VEGFR kinase designed at Novartis
Read More
MK-0431: a novel approach to type 2 diabetes
Read More
Potential new Alzheimer's therapeutic advances through the pipeline at Lilly
Read More
Novel series of Kv1.1 current disinactivators presented by Wyeth
Read More
Arena continues to advance product pipeline
Read More
Millennium presents new CCR8 antagonists for asthma and other disorders
Read More
Novel KCNQ channel openers discovered by ICAgen team
Read More
Gruenenthal claims agents for opioid receptor and/or 5-HT/norepinephrine uptake modulation
Read More
New caspase activators prepared and tested by Cytovia researchers
Read More
New triptolide derivatives and their use reported by Pharmagenesis researchers
Read More
Lundbeck patent covers novel KCNQ2 potassium channel openers
Read More
Merck KGaA describes 5-HT1A/5-HT4 ligands able to inhibit 5-HT reuptake
Read More
Crucell signs PER.C6 licensing agreement with Wyeth
Read More
XTL Biopharmaceuticals to enroll new patients in HepeX-C study
Read More
Verta receives grant for pilot HCV study of SCV-07
Read More
Enrollment completed in phase IIa study of MM-093
Read More
IND filing for Provecta
Read More
BioDelivery Sciences International closes Arius acquisition
Read More
NicOx and Pfizer team up for nitric oxide-donating compound development
Read More
Roche seeks European approval of Tarceva for NSCLC
Read More
New synthetic peroxide artemisinin analogue for malaria enters human clinical trials
Read More
Aphton seeks Canadian registration of Insegia in pancreatic cancer
Read More
Yamanouchi to roll out Vesicare in E.U.
Read More